Submitted by Anonymous (not verified) on 11 December 2025 - 16:15
Human medicines European public assessment report (EPAR): Teriflunomide Viatris (previously Teriflunomide Mylan), teriflunomide, Date of authorisation: 09/11/2022, Revision: 6, Status: Authorised
Source: